ArticleEuropean journal of hospital pharmacy : science and practice2023
Advanced ALK-positive lung cancer with lorlatinib versus crizotinib in Asian patients with brain metastases.
Hung Shih-ChangPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.